NCT04697459 (EX-CHRODIAL) is a NA clinical trial of chronic phase in Chronic Renal Failure, sponsored by University of Avignon.

Who is sponsoring NCT04697459?

NCT04697459 is sponsored by University of Avignon.

What drugs are being tested in NCT04697459?

Interventions in NCT04697459: chronic phase, acute phase.

What condition does NCT04697459 study?

NCT04697459 studies Chronic Renal Failure.

Is NCT04697459 still recruiting?

NCT04697459 is currently completed. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT04697459: EX-CHRODIAL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronic Intradialytic Exercise : a Cardioprotective Role

Completed NA Last updated 29 November 2023

What this trial tests

NA trial testing chronic phase in Chronic Renal Failure in 61 participants. Completed in 30 September 2023.

Timeline

13 December 2020

Primary endpoint
14 May 2023

30 September 2023

Quick facts

Lead sponsor	University of Avignon
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	61
Start date	13 December 2020
Primary completion	14 May 2023
Estimated completion	30 September 2023
Sites	2 locations across France

Drugs / interventions tested

chronic phase
acute phase

Conditions studied

Chronic Renal Failure — all drugs for Chronic Renal Failure →

Sponsor

University of Avignon

Who can join

Adults 20 to 79, any sex, with Chronic Renal Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to assess the effects of chronic intradialytic physical exercise on myocardial remodelling and regional function.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Cardioprotective Effect of Acute Intradialytic Exercise: A Comprehensive Speckle-Tracking Echocardiography Analysis.
Josse M, Patrier L, Isnard M, Turc-Baron C, et al · · 2023 · cited 11× · PMID 37071035 · DOI 10.1681/asn.0000000000000149
Effect of intradialytic exercise training on hemodialysis-induced myocardial stunning: a pilot-controlled trial.
Josse M, Patrier L, Cristol JP, Isnard M, et al · · 2025 · PMID 40008351 · DOI 10.1093/ckj/sfae352

Verify or expand the search:

Other recruiting trials for Chronic Renal Failure

Currently open trials in the same condition.

NCT06227468 — A Clinical Study to Map the HLA Genomic Region in the Greek Population · recruiting
NCT06347029 — Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure P · NA · recruiting
NCT05884866 — A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to B · Phase 2 · recruiting
NCT05353946 — Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure · NA · recruiting

Other University of Avignon trials

Trials by the same sponsor.

NCT07363993 — Interaction Between Intraventricular Flow and Cardiac Mechanics Using 3D Echocardiography in Athletes and Sedentary Subj · recruiting
NCT07269379 — Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients · NA · recruiting
NCT05942144 — Exercise-snacks at Work: Impact on Cardiometabolic Parameters · NA · terminated
NCT04605848 — Infrared Thermography Associated With Cutaneous Microcirculation for Detection of Brown-adipose Tissue (MICROBAT) · NA · terminated
NCT03847779 — Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04697459 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Avignon
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04697459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing